Abstract:Background/Aims: Acute myocardial infarction (AMI) is a devastating cardiovascular disease with a high rate of morbidity and mortality, partly due to enhanced arrhythmogenicity. MicroRNAs (miRNAs) have been shown to participate in the regulation of cardiac ion channels and the associated arrhythmias. The purpose of this study was to test our hypothesis that miR-223-3p contributes to the electrical disorders in AMI via modulating KCND2, the gene encoding voltage-gated channel Kv4.2 that carries transient outward K+ current I-to. Methods: AMI model was established in male Sprague-Dawley (SD) rats by left anterior descending artery (LAD) ligation. Evans blue and TTC staining was used to measure infarct area. I-to was recorded in isolated ventricular cardiomyocytes or cultured neonatal rat ventricular cells (NRVCs) by whole-cell patch-clamp techniques. Western blot analysis was employed to detect the protein level of Kv4.2 and real-time RT-PCR to determine the transcript level of miR-223-3p. Luciferase assay was used to examine the interaction between miR-223-3p and KCND2 in cultured NRVCs. Results: Expression of miR-223-3p was remarkably upregulated in AMI relative to sham control rats. On the contrary, the protein level of Kv4.2 and I-to density were significantly decreased in AMI. Consistently, transfection of miR-223-3p mimic markedly reduced Kv4.2 protein level and Ito current in cultured NRVCs. Co-transfection of AMO-223-3p (an antisense inhibitor of miR-223-3p) reversed the repressive effect of miR-223-3p. Luciferase assay showed that miR-223-3p, but not the negative control, substantially suppressed the luciferase activity, confirming the direct binding of miR-223-3p to the seed site within the KCND2 sequence. Finally, direct intramuscular injection of AMO-223-3p into the ischemic myocardium to knockdown endogenous miR-223-3p decreased the propensity of ischemic arrhythmias. Conclusions: Upregulation of miR-223-3p in AMI repressed the expression of KCND2/Kv4.2 resulting in reduction of I-to density that can cause APD prolongation and promote arrhythmias in AMI, and therefore knockdown of endogenous miR-223-3p might be considered a new approach for antiarrhythmic therapy of ischemic arrhythmias. (C) 2016 The Author(s) Published by S. Karger AG, Basel

Post-transcriptional regulation of cardiac sodium channel gene SCN5A expression and function by miR-192-5p

miR-190a-5p Partially Represses the Abnormal Electrical Activity of SCN3B in Cardiac Arrhythmias by Downregulation of IL-2

Abstract 15963: Microrna Biophysically Modulates Cardiac Physiology Via Directly Binding to Ion Channel

Regulation of human cardiac ion channel genes by microRNAs: theoretical perspective and pathophysiological implications

Dysregulated Expression of Micrornas and Mrnas in Myocardial Infarction.

Small Molecules, Big Effects: the Role of Micrornas in Regulation of Cardiomyocyte Death

Regulation of cardiac CACNB2 by microRNA-499: Potential role in atrial fibrillation.

MiR-223-3p as a Novel MicroRNA Regulator of Expression of Voltage-Gated K+ Channel Kv4.2 in Acute Myocardial Infarction.

Expression Profile Analysis of Circulating Micrornas and Their Effects on Ion Channels in Chinese Atrial Fibrillation Patients.

Mir-1231 Exacerbates Arrhythmia by Targeting Calciumchannel Gene CACNA2D2 in Myocardial Infarction.

MicroRNA-452-5p regulates fibrogenesis via targeting TGF-β/SMAD4 axis in SCN5A-knockdown human cardiac fibroblasts

Abstract 19722: Cardiac Deletion of miRNA-17-92 Cluster Augments Acute Myocardial Ischemia-Reperfusion Injury

Integrated Analysis of the microRNA–mRNA Network Predicts Potential Regulators of Atrial Fibrillation in Humans

Regulation of the SK3 channel by microRNA-499—Potential role in atrial fibrillation

Identification of miR-1 and miR-499 in chronic atrial fibrillation by bioinformatics analysis and experimental validation

miR-208a in Cardiac Hypertrophy and Remodeling

Silencing miR-370-3p rescues funny current and sinus node function in heart failure

Inhibiting microRNA-155 attenuates atrial fibrillation by targeting CACNA1C

Profiling Reduced Expression of Contractile and Mitochondrial mRNAs in the Human Sinoatrial Node vs. Right Atrium and Predicting Their Suppressed Expression by Transcription Factors and/or microRNAs

Abstract P3136: Alternative Polyadenylation Of Scn5a Generates A Novel N-terminal Nav1.5 Microprotein

Cardiovascular dysregulation of miR‐17‐92 causes a lethal hypertrophic cardiomyopathy and arrhythmogenesis